CSHP Oncology Community of Practice Event

Oncology-Hybrid-Webinar-Series.png

CSHP National would like to invite PTSA members to join them in-person for dinner & 1 CEU at the upcoming live Oncology Hybrid Series: CSHP Oncology Community of Practice event.

Date: September 29th from 6:00-8:00 pm MST

Presented by: Dr. Laetitia Treseng, BScPharm, PharmD.

Location: University of Alberta Peter Lougheed Hall, 5th Floor 11011 Saskatchewan Dr. NW Edmonton, AB T6G 2B4 CANADA

By the end of this session, participants will be able to: 

  • Review mechanism of action of immune checkpoint inhibitors 
  • Describe the possible adverse events caused by immune checkpoint inhibitors 
  • Discuss the management of immune-related adverse events (irAEs) 

Note: Live in-person dinner session capacity is limited to 50 attendees, therefore, early registration is recommended. Event is free for CSHP and PTSA members. PTSA members who are not CSHP members must use the promo code: ONC2026.

Registration and more information:

Management of Immune-Related Adverse Events (irAEs) Caused by Immune Checkpoint Inhibitors: In-Person Registration 

Management of Immune-Related Adverse Events (irAEs) Caused by Immune Checkpoint Inhibitors: Virtual Registration

Pending accreditation for 1 CEU.

About Dr. Laetitia Treseng, BScPharm, PharmD

Dr. Laetitia Treseng holds a Bachelor of Science in Pharmacy and a Doctor of Pharmacy from the University of Alberta. She is a gynecologic oncology pharmacist at the Cross Cancer Institute. Her practice focuses on comprehensive patient assessment and the management of systemic therapy and immune checkpoint inhibitor-associated toxicities within independent and multidisciplinary care frameworks. 


Join the conversation!

Your email address will not be published. If you are a PTSA member, login here now! Required fields are marked *